Moreover, Ginsenoside Rg3 shows promise in reducing the growth of cisplatin-resistant A549/DDP cells and their resistance to cisplatin by diminishing cisplatin-induced PD-L1 expression, which enhances T cell cytotoxicity against cancer cells [29]. Here, CD274 is linked to cancer.